Elevation Oncology

ELEV46

Penny Stock

$0.60arrow_drop_down0.59%-$0.00

Penny Stock

ELEV46

$0.60

arrow_drop_down0.59%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.61
Prev. Close	$0.60
EPS	-0.80
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$35.67M
PE Ratio	-

	LOW	HIGH
Day Range	0.59	0.62
52 Week Range	0.36	5.83

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.80

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Elevation Oncology (ELEV)

Elevation Oncology, Inc., also known by its stock ticker symbol ELEV, is a biotechnology company focused on developing precision medicines for the treatment of cancer. The company is dedicated to identifying and targeting specific genetic alterations in cancer patients in order to create personalized therapies that have the potential to be more effective and less toxic than traditional treatments. ELEV is committed to improving the lives of cancer patients by providing them with innovative treatment options that address the molecular drivers of their disease.

Elevation Oncology, Inc. offers a unique approach to cancer therapy by leveraging the power of genomic sequencing and precision medicine. By analyzing the genetic makeup of individual tumors, the company can identify specific mutations or alterations that are driving the growth and spread of the cancer. This information is then used to develop targeted therapies that are designed to directly attack and inhibit the growth of the cancer cells while sparing healthy cells. This personalized approach has the potential to revolutionize cancer treatment by improving patient outcomes and reducing the side effects associated with traditional therapies.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Joseph J. Ferra Jr.
Headquarters: New York
Employees: 33
Exchange: NASDAQ

Keep an eye on Elevation Oncology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Elevation Oncology's (ELEV) price per share?

The current price per share for Elevation Oncology (ELEV) is $0.6. The stock has seen a price change of -$0 recently, indicating a -0.59% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Elevation Oncology (ELEV)?

For Elevation Oncology (ELEV), the 52-week high is $5.83, which is 866.19% from the current price. The 52-week low is $0.36, the current price is 66.23% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Elevation Oncology (ELEV) a growth stock?

Elevation Oncology (ELEV) has shown an average price growth of -6.03% over the past three years. It has received a score of 11 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Elevation Oncology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Elevation Oncology (ELEV) stock price performance year to date (YTD)?

As of the latest data, Elevation Oncology (ELEV) has a year-to-date price change of -4.07%. Over the past month, the stock has experienced a price change of 3.11%. Over the last three months, the change has been -25.54%. Over the past six months, the figure is -83.82%.

help

Is Elevation Oncology (ELEV) a profitable company?

Elevation Oncology (ELEV) has a net income of -$45.7M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$45.44M. Furthermore, the EBITDA is -$41.98M.

help

What is the market capitalization of Elevation Oncology (ELEV)?

Elevation Oncology (ELEV) has a market capitalization of $35.67M. The average daily trading volume is 0.61, indicating the stock's liquidity and investor engagement.